Rincon lithium project: US$2.5bn cost, 60,000tpa capacity, DLE technology and 2028 production timeline
Read More Pharma Industry News How rare disease medicine access in Africa is moving from ad hoc supply to structured compliance-led programs How Veld Pharmaceuticals and Chiesi are reshaping rare disease drug access in Africa through compliance-led programs. Read what this means for the sector. bySoujanya RaviApril 15, 2026